Loomis Sayles & Co. L P Decreases Holdings in Doximity, Inc. (NASDAQ:DOCS)

Loomis Sayles & Co. L P lowered its holdings in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 8.1% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 2,272,231 shares of the company's stock after selling 200,621 shares during the quarter. Loomis Sayles & Co. L P owned approximately 1.22% of Doximity worth $99,001,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the business. Swedbank AB purchased a new stake in Doximity in the first quarter worth $91,673,000. William Blair Investment Management LLC boosted its stake in shares of Doximity by 15.8% during the 2nd quarter. William Blair Investment Management LLC now owns 6,404,068 shares of the company's stock valued at $179,122,000 after purchasing an additional 873,682 shares in the last quarter. Los Angeles Capital Management LLC increased its position in shares of Doximity by 6,242.6% during the third quarter. Los Angeles Capital Management LLC now owns 650,874 shares of the company's stock valued at $28,359,000 after buying an additional 640,612 shares during the period. Janus Henderson Group PLC raised its stake in Doximity by 33.5% in the first quarter. Janus Henderson Group PLC now owns 2,474,695 shares of the company's stock worth $66,594,000 after buying an additional 621,590 shares in the last quarter. Finally, Clearbridge Investments LLC lifted its holdings in Doximity by 7.1% in the second quarter. Clearbridge Investments LLC now owns 5,853,035 shares of the company's stock worth $163,709,000 after buying an additional 387,200 shares during the period. 87.19% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on DOCS. Canaccord Genuity Group downgraded Doximity from a "buy" rating to a "hold" rating and upped their target price for the stock from $40.00 to $60.00 in a report on Wednesday, November 13th. Wells Fargo & Company raised Doximity from an "underweight" rating to an "equal weight" rating and raised their price objective for the company from $19.00 to $41.00 in a research report on Friday, November 8th. Evercore ISI upped their target price on shares of Doximity from $34.00 to $45.00 and gave the stock an "in-line" rating in a research report on Tuesday, October 8th. Morgan Stanley upgraded shares of Doximity from an "underweight" rating to an "equal weight" rating and increased their price target for the stock from $33.00 to $53.00 in a research note on Thursday, November 14th. Finally, Barclays boosted their price objective on shares of Doximity from $52.00 to $75.00 and gave the stock an "overweight" rating in a research note on Monday, November 11th. Eleven analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $52.27.

Doximity Price Performance

Shares of Doximity stock traded up $0.55 during trading on Monday, hitting $48.75. 2,746,731 shares of the company's stock traded hands, compared to its average volume of 1,756,088. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $61.75. The business has a 50-day simple moving average of $44.64 and a 200-day simple moving average of $35.16. The stock has a market capitalization of $9.10 billion, a P/E ratio of 52.97, a PEG ratio of 3.91 and a beta of 1.30.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.